WARSAW — Zimmer Biomet Holdings, a global leader in musculoskeletal healthcare, announced it has received 510(k) clearance from the US Food and Drug Administration for the Unite3D Bridge Fixation System, a 3D-printed technology designed to offer stability in foot and ankle arthrodesis surgery. Featuring Zimmer Biomet’s proprietary OsseoTi porous metal technology, which mimics the architecture of …read more.